drugset / Trial / NCT02929823
Safety and Efficacy of SJP-0035 Ophthalmic Solution in Patients With Moderate to Severe Corneal Epithelial Disorders
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether SJP-0035 ophthalmic solution is effective in promoting corneal epithelial wound healing in conditions associated with corneal epithelial disorders.
Timeline
- Start
- 2016-09
- Primary completion
- 2017-05-03
- Completion
- 2017-05-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FONADELPAR | Small molecule | 0.0002 % | Other |
| Subject | FONADELPAR | Small molecule | 0.001 % | Other |